Mera - Ethical, accurate drug developmentbroad
MEra - Micro Era · Horizon Europe grant · 2023-10-01–2026-01-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2023-ACCELERATOR-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2023-ACCELERATOROPEN-01. CORDIS record →
Objective
Using patented fluid management technologies, the Mera system has the ability to culture, drug & stain 3D tissues on a large scale while monitoring everything in real time, through a fully automated florescent microscope. 3D microtissues are added to a dedicated consumable bio-plate. The plate is then integrated into the main Mera system. A chemical cocktail can be introduced to selected wells on a plate in order to mature the cells into different tissue types such as liver, heart, neuronal or cancer. The fluid pathway can be changed to allow the introduction of a drug or stain to batches of multiple different tissue types. The fluid can then be recirculated, replicating the conditions in the human body where organs interact with each other. The whole process can be monitored using the automated microscope in wide field or florescent modes. The system is modular & scalable, allowing a single unit to run up to 800 microtissues simultaneously.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| HOOKE BIO LTD | IE | coordinator | €2,499,999 | Yes |
Get the EU Defence Funding Calendar — free
The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.
Or browse all open defence & dual-use calls on the funding calendar →
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.